Nextgen Biomed Ltd
Tel Aviv Stock Exchange NXGN.TA
Nextgen Biomed Ltd Operating Income for the year ending December 31, 2023: USD -1.87 M
Nextgen Biomed Ltd Operating Income is USD -1.87 M for the year ending December 31, 2023, a 29.31% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.
-
Nextgen Biomed Ltd Operating Income for the year ending December 31, 2022 was USD -2.65 M, a -190.18% change year over year.
-
Nextgen Biomed Ltd Operating Income for the year ending December 31, 2021 was USD -913.00 K.
-
Nextgen Biomed Ltd Operating Income for the year ending December 31, 2019 was USD -358.70 K, a -10.88% change year over year.
Key data
| Date | Operating Income | EBIT | EBITDA | Net Income |
|---|
Market news
Loading...
Don’t Miss A Beat
Tel Aviv Stock Exchange: NXGN.TA
| CEO | Mr. Harel Hershtik |
| IPO Date | Aug. 12, 2002 |
| Location | Israel |
| Headquarters | 132 Azrieli Towers Round Building |
| Employees | 5 |
| Sector | Health Care |
| Industries | |
Description
Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.
Key trends
Past 5 years
StockViz Staff
February 6, 2025
Any question? Send us an email